Contact tracing to control infectious disease: When enough is enough

Health Care Management Science

Volumn 10, Issue 4, 2007, Pages 341-355

  Armbruster, Benjamin ^a   Brandeau, Margaret L ^a  

^a Stanford University   (United States)

Author keywords

Contact tracing; Cost effectiveness; Infectious disease; Network

Indexed keywords

ARTICLE; CHLAMYDIASIS; CONTACT EXAMINATION; COST BENEFIT ANALYSIS; DISEASE TRANSMISSION; ECONOMICS; HUMAN; MASS SCREENING; UNITED STATES; UTILIZATION REVIEW;

CHLAMYDIA INFECTIONS; CONTACT TRACING; COST-BENEFIT ANALYSIS; HUMANS; MASS SCREENING; UNITED STATES;

EID: 35348985872     PISSN: 13869620     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10729-007-9027-6     Document Type: Article

References (58)

1. Saretok P, Brouwers L (2007) Microsimulation of pandemic influenza in Sweden. In: Proceedings of the 2007 western multiconference on computer simulation, pp 73-78
2. Bozzette SA, Boer R, Bhatnagar V, Brower JL, Keeler EB, Morton SC, Stoto MA (2003) A model for a smallpox-vaccination policy. N Engl J Med 348(5):416-425
3. Hethcote HW (1982) Gonorrhea modeling: a comparison of control methods. Math Biosci 58:93-109
4. Zaric GS, Brandeau ML (2001) Resource allocation for epidemic control over short time horizons. Math Biosci 171:33-58
5. Zaric GS, Brandeau ML (2002) Dynamic resource allocation for epidemic control in multiple populations. IMA J Math Appl Med Biol 19:235-255
6. Longini IM Jr, Ackerman E, Elveback L (1978) An optimization model for influenza A epidemics. Math Biosci 38:141-157
7. Halloran ME, Longini IM Jr, Nizam A, Yang Y (2002) Containing bioterrorist smallpox. Science 298(5597):1428-1432
8. Müller J (1998) Optimal vaccination patterns in age-structured populations. SIAM J Appl Math 59:222-241
9. Revelle C, Feldmann F, Lynn W (1969) An optimization model tuberculosis epidemiology. Manage Sci 16(4):B190-B211
10. Centers for Disease Control and Prevention (2000) Chapter 10-community TB control: identification of persons who have clinically active TB, 2000. URL: http://www.cdc.gov/nchstp/tb/pubs/corecurr/Chapter10/Chapter_10_Identification. htm
11. Centers for Disease Control and Prevention (2002) Sexually transmitted diseases treatment guidelines 2002. URL: http://www.cdc.gov/STD/treatment/1- 2002TG.htm
12. Cowan FM, French R, Johnson AM (1996) The role and effectiveness of partner notification in STD control: a review. Genitourin Med 72:247-252
13. Clarke J (1998) Contact tracing for chlamydia: data on effectiveness. Int J STD AIDS 9:187-191
14. Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, Gopalakrishna G, Chew SK, Tan CC, Samore MH, Fisman D, Murray M (2003) Transmission dynamics and control of severe acute respiratory syndrome. Science 300(5627):1966-1970
15. Kiss IZ, Green DM, Kao RR (2005) Disease contact tracing in random and clustered networks. Proc R Soc Lond B Biol Sci 272:1407-1414
16. Porco TC, Holbrook KA, Fernyak SE, Portnoy DL, Reiter R, Aragón TJ (2004) Logistics of community smallpox control through contact tracing and ring vaccination: a stochastic network model. BMC Public Health 4:34
17. Kretzschmar M, van den Hof S, Wallinga J, van Wijngaarden J (2004) Ring vaccination and smallpox control. Emerg Infect Dis 10(5):832-841
18. Wu JT, Riley S, Fraser C, Leung GM (2006) Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Medicine 3:1532-1540
19. Hyman JM, Li J, Stanley EA (2003) Modeling the impact of random screening and contact tracing in reducing the spread of HIV. Math Biosci 181:17-54
20. Armbruster B, Brandeau ML (2007) Optimal mix of screening and contact tracing for endemic diseases. Math Biosci 209:386-402
21. Kretzschmar M (2000) Sexual network structure and sexually transmitted disease prevention: a modeling perspective. Sex Transm Dis 27:627-635
22. Müller J, Kretzschmar M, Dietz K (2000) Contact tracing in stochastic and deterministic epidemic models. Math Biosci 164:39-64
23. Huerta R, Tsimring LS (2002) Contact tracing and epidemics control in social networks. Phys Rev E Stat Nonlin Soft Matter Phys 66(5):56115
24. Eames KTD, Keeling MJ (2003) Contact tracing and disease control. Proc R Soc Lond B Biol Sci 270:2565-2571
25. Dasgupta K, Schwartzman K, Marchand R, Tennenbaum TN, Brassard P, Menzies D (2000) Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Crit Care Med 162(6):2079-2086
26. Macintyre CR, Plant AJ, Hendrie D (2000) The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis. Health Econ 9(5):411-421
27. Varghese B, Peterman TA, Holtgrave DR (1999) Cost-effectiveness of counseling and testing and partner notification: a decision analysis. AIDS 13(13):1745-1751
28. Cohen DA, Wu SY, Farley TA (2004) Comparing the cost-effectiveness of HIV prevention interventions. J Acquir Immune Defic Syndr 37(3):1404-1414
29. Howell MR, Kassler WJ, Haddix A (1997) Partner notification to prevent pelvic inflammatory disease in women: cost-effectiveness of two strategies. Sex Transm Dis 24(5):287-292
30. Oxman GL, Doyle L (1996) A comparison of the case-finding effectiveness and average costs of screening and partner notification. Sex Transm Dis 23(1):51-57
31. Welte R, Kretzschmar M, Postma MJ, Leidl R, van den Hoek JAR, Jager JC, Postma MJ (2000) Cost-effectiveness of screening programs for chlamydia trachomatis: a population based dynamic approach. Sex Transm Dis 27:518-529
32. Watts DJ, Strogatz SH (1998) Collective dynamics of 'small-world' networks. Nature 393:440-442
33. Schneeberger A, Mercer CH, Gregson SA, Ferguson NM, Nyamukapa CA, Anderson RM, Johnson AM, Garnett GP (2004) Scale-free networks and sexually transmitted diseases: a description of observed patterns of sexual contacts in Britain and Zimbabwe. Sex Transm Dis 31(6):380-387
34. Klovdahl AS, Potterat JJ, Woodhouse DE, Muth JB, Muth SQ, Darrow WW (1994) Social networks and infectious disease: the Colorado Springs study. Soc Sci Med 38(1):79-88
35. Weeks MR, Clair S, Borgatti SP, Radda K, Schensul JJ (2002) Social networks of drug users in high-risk sites: finding the connections. AIDS Behav 6(2):194-206
36. Parker M, Ward H, Day S (1998) Sexual networks and the transmission of HIV in London. J Biosoc Sci 30:63-83
37. Helleringer S, Kohler HP, Chimbiri A, Chatonda P, Mkandawire J (2007) The Likoma network study: context, data collection and survey instruments. URL: http://www.ssc.upenn.edu/~hpkohler/working-papers/hell06likdoc.pdf. Working paper
38. Wylie JL, Jolly A (2001) Patterns of chlamydia and gonorrhea infection in sexual networks in Manitoba, Canada. Sex Transm Dis 28(1):14-24
39. Armbruster B, Brandeau ML (2007) Who do you know? A simulation study of infectious disease control through contact tracing. In: Proceedings of the 2007 Western Multiconference on Computer Simulation, pp 79-85
40. Gold M, Siegel J, Russell L, Weinstein M (1996) Cost-effectiveness in health and medicine. Oxford Univ. Press
41. National Institutes of Health (2001) Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. URL: http://www.niaid.nih.gov/dmid/stds/condomreport.pdf
42. Centers for Disease Control and Prevention (2006) Fact sheet: gonorrhea. URL: http://www.cdc.gov/std/Gonorrhea/STDFact-gonorrhea.htm
43. Mehta SD, Bishai D, Howell MR, Rothman RE, Quinn TC, Zenilman JM (2002) Cost-effectiveness of five strategies for gonorrhea and chlamydia control among female and male emergency department patients. Sex Transm Dis 29(2):83-91
44. Centers for Disease Control and Prevention (2001) Program evaluation. URL: http://www.cdc.gov/std/program/training/TOC-PGtraining.htm
45. Neumann P, et al. (2001) Preference weights 1998-2001. URL: http://www.tufts-nemc.org/cearegistry/data/docs/phaseIIpreferenceweights.pdf
46. Owens DK (1998) Interpretation of cost-effectiveness analyses. J Gen Intern Med 13:716-717
47. U.S. Citizenship and Immigration Services (2006) Medical examinations. URL: http://www.uscis.gov/propub/ProPubVAP.jsp?dockey= 1c56d78b831659735c9fd1c1f7dbd68f
48. Citizenship and Immigration Canada (2002) Fact sheet-medical testing and surveillance. URL: http://www.cic.gc.ca/english/pub/fs-medical.html
49. World Health Organization (2001) Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. URL: http://www.who.int/docstore/hiv/GRSTI/index.htm
50. Centers for Disease Control and Prevention (2006) Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 55(RR14):1-17
51. Webb AL (2004) But I didn't know., 2004. Philadelphia City Paper January 22
52. Centers for Disease Control and Prevention (2005) STD surveillance 2005 national profile-chlamydia. URL: http://www.cdc.gov/std/stats/chlamydia.htm
53. National Institutes of Health (2006) Chlamydia. URL: http://www.niaid. nih.gov/factsheets/stdclam.htm
54. Zimmerman HL, Potterat JJ, Dukes RL, Muth JB, Zimmerman HP, Fogle JS, Pratts CI (1990) Epidemiologic differences between chlamydia and gonorrhea. Am J Public Health 80(11):1338-1342
55. Hu D, Hook EW 3rd, Goldie SJ (2004) Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis. Ann Intern Med 141:501-513
56. Kaplan EH, Craft DL, Wein LM (2002) Emergency response to a smallpox attack: the case for mass vaccination. PNAS 99(16):10935-10940
57. Centers for Disease Control and Prevention (2007) Extensively drug-resistant tuberculosis-United States, 1993-2006. MMWR 56(11):250-253
58. Centers for Disease Control and Prevention (2007) Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR 56(14):332-336